The Lipid Kinase PI4KIIIβ Is Highly Expressed in Breast Tumors and Activates Akt in Cooperation with Rab11a

Emerging evidence now implicates phosphatidylinositol 4-kinases (PI4K), enzymes that generate PI(4)P from phosphatidylinositol (PtdIns), in cancer. In this study, we investigate the role of PI4KIIIβ, one of four mammalian PI4Ks, in breast cancer. Although PI4KIIIβ protein levels are low in normal breast tissue, we find that approximately 20% of primary human breast tumors overexpress it. Expression of PI4KIIIβ in breast carcinoma cells leads to increased Akt activation, dependent on increased PI(3,4,5)P3 production. However, a kinase-inactive version of PI4KIIIβ also led to increased Akt activation, and no changes in PI(4)P or PI(4,5)P2 lipid abundance were detected in the PI4KIIIβ-overexpressing cells. This implies that PI4KIIIβ regulates PI(3,4,5)P3 and Akt independent of PI(4)P production. We find that the PI4KIIIβ-binding protein, Rab11a, a small GTPase that regulates endosomal recycling, is involved in PI4KIIIβ-mediated activation of Akt, as RNAi depletion of Rab11a impairs Akt activation. Furthermore, ectopic PI4KIIIβ expression alters cellular Rab11a distribution and enhances recruitment of PI4KIIIβ and Rab11a to recycling endosomes. This work suggests that PI4KIIIβ affects PI3K/Akt signaling through Rab11a and endosomal trafficking, independent of its lipid kinase activity. Thus, PI4KIIIβ likely plays a role in breast oncogenesis and that cooperation between Rab11a and PI4KIIIβ represents a novel Akt activation pathway. Mol Cancer Res; 12(10); 1492–508. ©2014 AACR.

[1]  R. Lothe,et al.  Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes , 2013, Breast Cancer Research and Treatment.

[2]  M. Waugh.  Phosphatidylinositol 4-kinases, phosphatidylinositol 4-phosphate and cancer. , 2012, Cancer letters.

[3]  C. Eng,et al.  PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome. , 2012, The Journal of clinical endocrinology and metabolism.

[4]  K. Mahajan,et al.  PI3K‐independent AKT activation in cancers: A treasure trove for novel therapeutics , 2012, Journal of cellular physiology.

[5]  K. Inoki,et al.  Phosphatidylinositol 3,5-bisphosphate plays a role in the activation and subcellular localization of mechanistic target of rapamycin 1 , 2012, Molecular biology of the cell.

[6]  P. Pandolfi,et al.  The functions and regulation of the PTEN tumour suppressor , 2012, Nature Reviews Molecular Cell Biology.

[7]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[8]  C. Feschotte,et al.  Endogenous viruses: insights into viral evolution and impact on host biology , 2012, Nature Reviews Genetics.

[9]  D. Pinke,et al.  The lipid kinase PI4KIIIβ and the eEF1A2 oncogene co-operate to disrupt three-dimensional in vitro acinar morphogenesis. , 2011, Experimental cell research.

[10]  A. Wandinger-Ness,et al.  Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities , 2011, Clinical genetics.

[11]  J. Hsuan,et al.  Differential effects of the phosphatidylinositol 4-kinases, PI4KIIα and PI4KIIIβ, on Akt activation and apoptosis , 2010, Cell Death and Disease.

[12]  R. Alexander,et al.  Early Endosomal Antigen 1 (EEA1) Is an Obligate Scaffold for Angiotensin II-induced, PKC-α-dependent Akt Activation in Endosomes* , 2010, The Journal of Biological Chemistry.

[13]  C. Cameron,et al.  Viral Reorganization of the Secretory Pathway Generates Distinct Organelles for RNA Replication , 2010, Cell.

[14]  Tom D. Bunney,et al.  Phosphoinositide signalling in cancer: beyond PI3K and PTEN , 2010, Nature Reviews Cancer.

[15]  J. Li,et al.  VAV2 regulates epidermal growth factor receptor endocytosis and degradation , 2010, Oncogene.

[16]  Robert L Sutherland,et al.  PI3K pathway activation in breast cancer is associated with the basal‐like phenotype and cancer‐specific mortality , 2010, International journal of cancer.

[17]  T. Balla,et al.  Dual roles for the Drosophila PI 4-kinase Four wheel drive in localizing Rab11 during cytokinesis , 2009, The Journal of cell biology.

[18]  G. Cottrell,et al.  Endosomes: A legitimate platform for the signaling train , 2009, Proceedings of the National Academy of Sciences.

[19]  P. Pandolfi,et al.  Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. , 2009, Cancer cell.

[20]  G. Schiavo,et al.  Immunocytochemical techniques reveal multiple, distinct cellular pools of PtdIns4P and PtdIns(4,5)P2 , 2009, The Biochemical journal.

[21]  P. Majerus,et al.  Regulation of PI(3)K/Akt signalling and cellular transformation by inositol polyphosphate 4‐phosphatase‐1 , 2009, EMBO reports.

[22]  S. Baker,et al.  PTEN and the PI3-kinase pathway in cancer. , 2009, Annual review of pathology.

[23]  L. Cantley,et al.  PI3K pathway alterations in cancer: variations on a theme , 2008, Oncogene.

[24]  W. Lam,et al.  PIK3CA mutations and copy number gains in human lung cancers. , 2008, Cancer research.

[25]  T. Balla,et al.  G protein-coupled receptor-promoted trafficking of Gbeta1gamma2 leads to AKT activation at endosomes via a mechanism mediated by Gbeta1gamma2-Rab11a interaction. , 2008, Molecular biology of the cell.

[26]  C. Collinet,et al.  The Endosomal Protein Appl1 Mediates Akt Substrate Specificity and Cell Survival in Vertebrate Development , 2008, Cell.

[27]  Pascale G. Charest,et al.  The regulation of cell motility and chemotaxis by phospholipid signaling , 2008, Journal of Cell Science.

[28]  K. Shokat,et al.  Maintenance of hormone-sensitive phosphoinositide pools in the plasma membrane requires phosphatidylinositol 4-kinase IIIalpha. , 2007, Molecular biology of the cell.

[29]  Jonathan M Lee,et al.  Binding of Elongation Factor eEF1A2 to Phosphatidylinositol 4-Kinase β Stimulates Lipid Kinase Activity and Phosphatidylinositol 4-Phosphate Generation* , 2007, Journal of Biological Chemistry.

[30]  Thomas D. Wu,et al.  Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer , 2007, Breast Cancer Research and Treatment.

[31]  Kevan M Shokat,et al.  Phosphatidylinositol 4-Kinase IIIβ Regulates the Transport of Ceramide between the Endoplasmic Reticulum and Golgi* , 2006, Journal of Biological Chemistry.

[32]  P. Várnai,et al.  Live cell imaging of phosphoinositide dynamics with fluorescent protein domains. , 2006, Biochimica et biophysica acta.

[33]  Yue Sun,et al.  Movin' on up: the role of PtdIns(4,5)P(2) in cell migration. , 2006, Trends in cell biology.

[34]  Robbie Loewith,et al.  A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling , 2006, Cell.

[35]  Naomi R Wray,et al.  Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours , 2005, BMC Cancer.

[36]  A. Mercurio,et al.  Hypoxia stimulates carcinoma invasion by stabilizing microtubules and promoting the Rab11 trafficking of the alpha6beta4 integrin. , 2005, Cancer research.

[37]  G. Mills,et al.  Emerging role of RAB GTPases in cancer and human disease. , 2005, Cancer research.

[38]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[39]  Hiroyuki Konishi,et al.  The PIK3CA gene is mutated with high frequency in human breast cancers , 2004, Cancer biology & therapy.

[40]  W. Zwart,et al.  Phosphatidylinositol 4-kinasebeta is critical for functional association of rab11 with the Golgi complex. , 2004, Molecular biology of the cell.

[41]  J. Blenis,et al.  PI3K induced actin filament remodeling through Akt and p70S6K1: implication of essential role in cell migration. , 2004, American journal of physiology. Cell physiology.

[42]  Y. Umezawa,et al.  Production of PtdInsP3 at endomembranes is triggered by receptor endocytosis , 2003, Nature Cell Biology.

[43]  Jayanta Debnath,et al.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. , 2003, Methods.

[44]  H. Egami,et al.  Identification of genes related to invasion and metastasis in pancreatic cancer by cDNA representational difference analysis. , 2003, Journal of experimental & clinical cancer research : CR.

[45]  Zhixiang Wang,et al.  Endosomal Signaling of Epidermal Growth Factor Receptor Stimulates Signal Transduction Pathways Leading to Cell Survival , 2002, Molecular and Cellular Biology.

[46]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[47]  J. Gray,et al.  Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer , 2002, Nature Genetics.

[48]  Richard A. Firtel,et al.  Spatial and Temporal Regulation of 3-Phosphoinositides by PI 3-Kinase and PTEN Mediates Chemotaxis , 2002, Cell.

[49]  P. Depowski,et al.  Loss of Expression of the PTEN Gene Protein Product Is Associated with Poor Outcome in Breast Cancer , 2001, Modern Pathology.

[50]  Y. Chen,et al.  Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. , 2000, Journal of the National Cancer Institute.

[51]  I. Wistuba,et al.  Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines. , 2000, Cancer genetics and cytogenetics.

[52]  K. Moelling,et al.  Phosphorylation and regulation of Raf by Akt (protein kinase B). , 1999, Science.

[53]  L. Mulligan,et al.  Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. , 1999, The American journal of pathology.

[54]  A. Luini,et al.  ARF mediates recruitment of PtdIns-4-OH kinase-β and stimulates synthesis of PtdIns(4,5)P2 on the Golgi complex , 1999, Nature Cell Biology.

[55]  D. Treré,et al.  c‐erbB‐2 over‐expression in amplified and non‐amplified breast carcinoma samples , 1999, International journal of cancer.

[56]  J Isola,et al.  Molecular cytogenetics of primary breast cancer by CGH , 1998, Genes, chromosomes & cancer.

[57]  P. Cohen,et al.  Role of Translocation in the Activation and Function of Protein Kinase B* , 1997, The Journal of Biological Chemistry.

[58]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[59]  David R. Kaplan,et al.  Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate , 1997, Science.

[60]  S. Schmid,et al.  Control of EGF Receptor Signaling by Clathrin-Mediated Endocytosis , 1996, Science.

[61]  M. Zerial,et al.  Rab11 regulates recycling through the pericentriolar recycling endosome , 1996, The Journal of cell biology.

[62]  J. Cheng,et al.  Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[63]  N. Ruderman,et al.  Insulin-stimulated phosphatidylinositol 3-kinase. Association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low density membrane vesicle. , 1993, The Journal of biological chemistry.

[64]  J. Cheng,et al.  AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.